Intravenous (IV) Flagyl Administration: Process and Considerations

Always follow your physician’s specific instructions and hospital protocols. Administer IV Flagyl (metronidazole) via a slow intravenous infusion, typically over 30-60 minutes. Rapid infusion can lead to adverse effects.

Dosage: The prescribed dosage depends on the patient’s condition and weight; carefully check the order and prepare the medication accurately. Dilute the medication in a compatible IV fluid as per the manufacturer’s guidelines. Common diluents include dextrose 5% in water (D5W) or normal saline (0.9% NaCl).

Monitoring: Closely monitor the patient for infusion-related reactions, including phlebitis. Observe the IV site for signs of inflammation or infiltration. Regularly assess vital signs. Report any adverse events immediately.

Side effects: Be aware of potential side effects such as nausea, vomiting, diarrhea, headache, dizziness, and metallic taste. Less common, but serious, side effects include seizures and peripheral neuropathy. Inform medical personnel if the patient experiences any of these.

Medication interactions: Review the patient’s medication history for potential drug interactions. Metronidazole can interact with anticoagulants, alcohol, and certain antidepressants. Consult drug interaction resources to ensure safe administration.

Patient education: Before discharge, ensure the patient understands potential side effects and the importance of reporting any issues to their physician. Provide clear instructions regarding medication adherence and follow-up appointments.

Disposal: Dispose of any unused medication according to hospital policy and local regulations.